723 Clinical nodal staging scores for prostate cancer: A proposal for preoperative risk assessment
Luis Kluth(Goethe University Frankfurt), Shahrokh F. Shariat(Universitätszahnklinik Wien), Markus Graefen(Eppendorf (Germany)), Sascha Ahyai(Medical University of Graz), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Karl Pummer(Medical University of Graz), Aaron Becker, Yair Lotan(Southwestern Medical Center), Douglas S. Scherr(Cornell University), C. Seitz(Medical University of Vienna), Murat Gönen, Daniel Seiler(University of Lübeck), Firas Abdollah(Henry Ford Health System), Francesco Montorsi(Vita-Salute San Raffaele University), R.K. Lee, Alessandro Nonis(Vita-Salute San Raffaele University), Paul Schramek(Krankenhaus Barmherzige Brüder), Harun Fajković(University of Applied Sciences St Pölten), Wolfgang Loidl(Ordensklinikum Linz Barmherzige Schwestern), E. Xylinas, Alok K. Tewari(Harvard University), Malte Rieken, P. Karakiewicz, Mengmeng Sun, Michael Herman(Borland Groover Clinic), Jens Hansen, A. Bachmann(University Hospital of Basel), Behfar Ehdaie(NewYork–Presbyterian Hospital)
Cited by 1
Related Papers
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
|Cancer Cell|2021|624
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359